Felodipine Sustained-Release Tablet  Market Report

Global Felodipine Sustained-Release Tablet Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：227
  • REPORT CODE：GMM873508
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Felodipine Sustained-Release Tablet market report explains the definition, types, applications, major countries, and major players of the Felodipine Sustained-Release Tablet market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Changzhou Siyao Pharmaceutical

    • Lifeon

    • Sandoz

    • SHANXI KANGBO BIOLOGICAL PRODUCT

    • Mylan

    • NanJing Easeheal Phaemaecutical

    • Astrazeneca

    By Type:

    • 25mg Per Tablet

    • 5mg Per Tablet

    • Others

    By End-User:

    • Treat High Blood Pressure

    • Relieve Angina

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Felodipine Sustained-Release Tablet Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Felodipine Sustained-Release Tablet Outlook to 2028- Original Forecasts

    • 2.2 Felodipine Sustained-Release Tablet Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Felodipine Sustained-Release Tablet Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Felodipine Sustained-Release Tablet Market- Recent Developments

    • 6.1 Felodipine Sustained-Release Tablet Market News and Developments

    • 6.2 Felodipine Sustained-Release Tablet Market Deals Landscape

    7 Felodipine Sustained-Release Tablet Raw Materials and Cost Structure Analysis

    • 7.1 Felodipine Sustained-Release Tablet Key Raw Materials

    • 7.2 Felodipine Sustained-Release Tablet Price Trend of Key Raw Materials

    • 7.3 Felodipine Sustained-Release Tablet Key Suppliers of Raw Materials

    • 7.4 Felodipine Sustained-Release Tablet Market Concentration Rate of Raw Materials

    • 7.5 Felodipine Sustained-Release Tablet Cost Structure Analysis

      • 7.5.1 Felodipine Sustained-Release Tablet Raw Materials Analysis

      • 7.5.2 Felodipine Sustained-Release Tablet Labor Cost Analysis

      • 7.5.3 Felodipine Sustained-Release Tablet Manufacturing Expenses Analysis

    8 Global Felodipine Sustained-Release Tablet Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Felodipine Sustained-Release Tablet Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Felodipine Sustained-Release Tablet Export by Region (Top 10 Countries) (2017-2028)

    9 Global Felodipine Sustained-Release Tablet Market Outlook by Types and Applications to 2022

    • 9.1 Global Felodipine Sustained-Release Tablet Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 25mg Per Tablet Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 5mg Per Tablet Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Felodipine Sustained-Release Tablet Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Treat High Blood Pressure Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Relieve Angina Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Felodipine Sustained-Release Tablet Market Analysis and Outlook till 2022

    • 10.1 Global Felodipine Sustained-Release Tablet Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.2.2 Canada Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.2.3 Mexico Felodipine Sustained-Release Tablet Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.2 UK Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.3 Spain Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.4 Belgium Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.5 France Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.6 Italy Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.7 Denmark Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.8 Finland Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.9 Norway Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.10 Sweden Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.11 Poland Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.12 Russia Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.3.13 Turkey Felodipine Sustained-Release Tablet Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.2 Japan Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.3 India Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.4 South Korea Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.5 Pakistan Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.6 Bangladesh Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.7 Indonesia Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.8 Thailand Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.9 Singapore Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.10 Malaysia Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.11 Philippines Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.4.12 Vietnam Felodipine Sustained-Release Tablet Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.5.2 Colombia Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.5.3 Chile Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.5.4 Argentina Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.5.5 Venezuela Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.5.6 Peru Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.5.7 Puerto Rico Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.5.8 Ecuador Felodipine Sustained-Release Tablet Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.6.2 Kuwait Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.6.3 Oman Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.6.4 Qatar Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Felodipine Sustained-Release Tablet Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.7.2 South Africa Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.7.3 Egypt Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.7.4 Algeria Felodipine Sustained-Release Tablet Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Felodipine Sustained-Release Tablet Consumption (2017-2022)

      • 10.8.2 New Zealand Felodipine Sustained-Release Tablet Consumption (2017-2022)

    11 Global Felodipine Sustained-Release Tablet Competitive Analysis

    • 11.1 Changzhou Siyao Pharmaceutical

      • 11.1.1 Changzhou Siyao Pharmaceutical Company Details

      • 11.1.2 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Main Business and Markets Served

      • 11.1.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Lifeon

      • 11.2.1 Lifeon Company Details

      • 11.2.2 Lifeon Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Lifeon Felodipine Sustained-Release Tablet Main Business and Markets Served

      • 11.2.4 Lifeon Felodipine Sustained-Release Tablet Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Sandoz

      • 11.3.1 Sandoz Company Details

      • 11.3.2 Sandoz Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Sandoz Felodipine Sustained-Release Tablet Main Business and Markets Served

      • 11.3.4 Sandoz Felodipine Sustained-Release Tablet Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 SHANXI KANGBO BIOLOGICAL PRODUCT

      • 11.4.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Details

      • 11.4.2 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Main Business and Markets Served

      • 11.4.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Mylan

      • 11.5.1 Mylan Company Details

      • 11.5.2 Mylan Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Mylan Felodipine Sustained-Release Tablet Main Business and Markets Served

      • 11.5.4 Mylan Felodipine Sustained-Release Tablet Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 NanJing Easeheal Phaemaecutical

      • 11.6.1 NanJing Easeheal Phaemaecutical Company Details

      • 11.6.2 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Main Business and Markets Served

      • 11.6.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Astrazeneca

      • 11.7.1 Astrazeneca Company Details

      • 11.7.2 Astrazeneca Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Astrazeneca Felodipine Sustained-Release Tablet Main Business and Markets Served

      • 11.7.4 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Felodipine Sustained-Release Tablet Market Outlook by Types and Applications to 2028

    • 12.1 Global Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 25mg Per Tablet Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global 5mg Per Tablet Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Treat High Blood Pressure Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Relieve Angina Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Felodipine Sustained-Release Tablet Market Analysis and Outlook to 2028

    • 13.1 Global Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.2.2 Canada Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.2 UK Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.3 Spain Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.5 France Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.6 Italy Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.8 Finland Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.9 Norway Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.11 Poland Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.12 Russia Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.2 Japan Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.3 India Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.5.3 Chile Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.5.6 Peru Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.6.3 Oman Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Felodipine Sustained-Release Tablet Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Felodipine Sustained-Release Tablet

    • Figure of Felodipine Sustained-Release Tablet Picture

    • Table Global Felodipine Sustained-Release Tablet Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Felodipine Sustained-Release Tablet Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 25mg Per Tablet Consumption and Growth Rate (2017-2022)

    • Figure Global 5mg Per Tablet Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Treat High Blood Pressure Consumption and Growth Rate (2017-2022)

    • Figure Global Relieve Angina Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Felodipine Sustained-Release Tablet Consumption by Country (2017-2022)

    • Table North America Felodipine Sustained-Release Tablet Consumption by Country (2017-2022)

    • Figure United States Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Canada Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Mexico Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Table Europe Felodipine Sustained-Release Tablet Consumption by Country (2017-2022)

    • Figure Germany Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure UK Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Spain Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Belgium Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure France Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Italy Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Denmark Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Finland Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Norway Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Sweden Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Poland Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Russia Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Turkey Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Table APAC Felodipine Sustained-Release Tablet Consumption by Country (2017-2022)

    • Figure China Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Japan Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure India Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure South Korea Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Thailand Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Singapore Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Philippines Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Table South America Felodipine Sustained-Release Tablet Consumption by Country (2017-2022)

    • Figure Brazil Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Colombia Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Chile Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Argentina Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Peru Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Table GCC Felodipine Sustained-Release Tablet Consumption by Country (2017-2022)

    • Figure Bahrain Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Oman Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Qatar Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Table Africa Felodipine Sustained-Release Tablet Consumption by Country (2017-2022)

    • Figure Nigeria Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure South Africa Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Egypt Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure Algeria Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Table Oceania Felodipine Sustained-Release Tablet Consumption by Country (2017-2022)

    • Figure Australia Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Felodipine Sustained-Release Tablet Consumption and Growth Rate (2017-2022)

    • Table Changzhou Siyao Pharmaceutical Company Details

    • Table Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

    • Table Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Main Business and Markets Served

    • Table Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio

    • Table Lifeon Company Details

    • Table Lifeon Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lifeon Felodipine Sustained-Release Tablet Main Business and Markets Served

    • Table Lifeon Felodipine Sustained-Release Tablet Product Portfolio

    • Table Sandoz Company Details

    • Table Sandoz Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz Felodipine Sustained-Release Tablet Main Business and Markets Served

    • Table Sandoz Felodipine Sustained-Release Tablet Product Portfolio

    • Table SHANXI KANGBO BIOLOGICAL PRODUCT Company Details

    • Table SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

    • Table SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Main Business and Markets Served

    • Table SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio

    • Table Mylan Company Details

    • Table Mylan Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Felodipine Sustained-Release Tablet Main Business and Markets Served

    • Table Mylan Felodipine Sustained-Release Tablet Product Portfolio

    • Table NanJing Easeheal Phaemaecutical Company Details

    • Table NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

    • Table NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Main Business and Markets Served

    • Table NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio

    • Table Astrazeneca Company Details

    • Table Astrazeneca Felodipine Sustained-Release Tablet Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Felodipine Sustained-Release Tablet Main Business and Markets Served

    • Table Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio

    • Figure Global 25mg Per Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 5mg Per Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Treat High Blood Pressure Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Relieve Angina Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Felodipine Sustained-Release Tablet Consumption Forecast by Country (2022-2028)

    • Table North America Felodipine Sustained-Release Tablet Consumption Forecast by Country (2022-2028)

    • Figure United States Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Felodipine Sustained-Release Tablet Consumption Forecast by Country (2022-2028)

    • Figure Germany Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Felodipine Sustained-Release Tablet Consumption Forecast by Country (2022-2028)

    • Figure China Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Felodipine Sustained-Release Tablet Consumption Forecast by Country (2022-2028)

    • Figure Brazil Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Felodipine Sustained-Release Tablet Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Felodipine Sustained-Release Tablet Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Felodipine Sustained-Release Tablet Consumption Forecast by Country (2022-2028)

    • Figure Australia Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Felodipine Sustained-Release Tablet Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US